Unstable angina non ST elevation myocardial infarction analgesics: Difference between revisions
Jump to navigation
Jump to search
Esther Lee (talk | contribs) /* ACC / AHA Guidelines (DO NOT EDIT) {{cite journal |author=Anderson JL, Adams CD, Antman EM, et al |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the America... |
Esther Lee (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
*[[Morphine sulfate]] is reasonable for patients whose symptoms are not relieved despite [[nitroglycerine]] (NTG) (e.g., after 3 serial sublingual [[NTG]] tablets) or whose symptoms recur despite adequate anti-ischemic therapy. | *[[Morphine sulfate]] is reasonable for patients whose symptoms are not relieved despite [[nitroglycerine]] (NTG) (e.g., after 3 serial sublingual [[NTG]] tablets) or whose symptoms recur despite adequate anti-ischemic therapy. | ||
==ACC / AHA Guidelines (DO NOT EDIT) <ref name="pmid17692738">{{cite journal |author=Anderson JL, Adams CD, Antman EM, ''et al'' |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine |journal=JACC |volume=50 |issue=7 |pages=e1–e157 |year=2007 |month=August |pmid=17692738 |doi:10.1016/j.jacc.2007.02.013 |url= | ==ACC / AHA 2007 Guidelines - Unstable Angina / NSTEMI - Analgesics (DO NOT EDIT) <ref name="pmid17692738">{{cite journal |author=Anderson JL, Adams CD, Antman EM, ''et al'' |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine |journal=JACC |volume=50 |issue=7 |pages=e1–e157 |year=2007 |month=August |pmid=17692738 |doi:10.1016/j.jacc.2007.02.013 |url=}}</ref>== | ||
{ | {|class="wikitable" | ||
== | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"| | |||
<nowiki>"</nowiki>'''1.''' Because of the increased risks of mortality, [[re]]infarction, [[hypertension]], [[heart failure]], and [[myocardial rupture]] associated with their use, [[non steroidal anti-inflammatory drugs]] ([[NSAIDs]]), except for [[ASA]], whether non selective or cyclo oxygenase (COX)-2–selective agents, should be discontinued at the time a patient presents with [[Unstable angina]] / [[NSTEMI]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level: C]])<nowiki>"</nowiki> | |||
|} | |||
'''1.''' | {|class="wikitable" | ||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] | |||
|- | |||
|bgcolor="LightCoral"| | |||
<nowiki>"</nowiki>'''1.'''[[Non steroidal anti-inflammatory drugs]] (except for [[ASA]]), whether non selective or COX-2–selective agents, should not be administered during hospitalization for [[Unstable angina]] / [[NSTEMI]] because of the increased risks of mortality, [[re]]infarction, [[hypertension]], [[HF]], and [[myocardial rupture]] associated with their use. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level C]])<nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" | |||
|- | |||
== | | colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |||
'''1.''' In the absence of contradictions to its use, it is reasonable to administer [[morphine sulfate]] intravenously to [[Unstable angina]] / [[NSTEMI]] patients if there is uncontrolled ischemic chest discomfort despite [[NTG]], provided that additional therapy is used to manage the underlying [[ischemia]]. (Level of Evidence: B) | | bgcolor="LemonChiffon"| | ||
<nowiki>"</nowiki>'''1.''' In the absence of contradictions to its use, it is reasonable to administer [[morphine sulfate]] intravenously to [[Unstable angina]] / [[NSTEMI]] patients if there is uncontrolled ischemic chest discomfort despite [[NTG]], provided that additional therapy is used to manage the underlying [[ischemia]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level: B]])<nowiki>"</nowiki> | |||
|} | |||
==Sources== | ==Sources== | ||
* The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction <ref name="pmid17692738">{{cite journal |author=Anderson JL, Adams CD, Antman EM, ''et al'' |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine |journal=JACC |volume=50 |issue=7 |pages=e1–e157 |year=2007 |month=August |pmid=17692738 |doi:10.1016/j.jacc.2007.02.013 |url=}}</ref> | * The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction <ref name="pmid17692738">{{cite journal |author=Anderson JL, Adams CD, Antman EM, ''et al'' |title=ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine |journal=JACC |volume=50 |issue=7 |pages=e1–e157 |year=2007 |month=August |pmid=17692738 |doi:10.1016/j.jacc.2007.02.013 |url=}}</ref> | ||
Revision as of 16:24, 10 October 2012
|
Unstable angina / NSTEMI Microchapters |
|
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
|
Special Groups |
|
Diagnosis |
|
Laboratory Findings |
|
Treatment |
|
Antitplatelet Therapy |
|
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
|
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
|
Mechanical Reperfusion |
|
Discharge Care |
|
Case Studies |
|
Unstable angina non ST elevation myocardial infarction analgesics On the Web |
|
FDA on Unstable angina non ST elevation myocardial infarction analgesics |
|
CDC onUnstable angina non ST elevation myocardial infarction analgesics |
|
Unstable angina non ST elevation myocardial infarction analgesics in the news |
|
Blogs on Unstable angina non ST elevation myocardial infarction analgesics |
|
to Hospitals Treating Unstable angina non ST elevation myocardial infarction analgesics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.; Neil Gheewala, M.D. [3]
Mechanism of Benefit
- Morphine causes venodilation and can produce modest reductions in heart rate (through increased vagal tone) and systolic blood pressure to further reduce myocardial oxygen demand[1].
- Morphine sulfate has potent analgesic and anxiolytic effects, as well as hemodynamic effects, that are potentially beneficial in Unstable angina/NSTEMI.
Indications
- Morphine sulfate is reasonable for patients whose symptoms are not relieved despite nitroglycerine (NTG) (e.g., after 3 serial sublingual NTG tablets) or whose symptoms recur despite adequate anti-ischemic therapy.
ACC / AHA 2007 Guidelines - Unstable Angina / NSTEMI - Analgesics (DO NOT EDIT) [1]
| Class I |
|
"1. Because of the increased risks of mortality, reinfarction, hypertension, heart failure, and myocardial rupture associated with their use, non steroidal anti-inflammatory drugs (NSAIDs), except for ASA, whether non selective or cyclo oxygenase (COX)-2–selective agents, should be discontinued at the time a patient presents with Unstable angina / NSTEMI. (Level: C)" |
| Class III |
|
"1.Non steroidal anti-inflammatory drugs (except for ASA), whether non selective or COX-2–selective agents, should not be administered during hospitalization for Unstable angina / NSTEMI because of the increased risks of mortality, reinfarction, hypertension, HF, and myocardial rupture associated with their use. (Level C)" |
| Class IIa |
|
"1. In the absence of contradictions to its use, it is reasonable to administer morphine sulfate intravenously to Unstable angina / NSTEMI patients if there is uncontrolled ischemic chest discomfort despite NTG, provided that additional therapy is used to manage the underlying ischemia. (Level: B)" |
Sources
- The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [1]
References
- ↑ 1.0 1.1 1.2 Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". Journal of the American College of Cardiology. 50 (7): e1–e157. doi:10.1016/j.jacc.2007.02.013. PMID 17692738. Retrieved 2011-04-11. Unknown parameter
|month=ignored (help)